~~<i id='2BE3D57C29'><strike id='2BE3D57C29'><tt id='2BE3D57C29'><pre id='2BE3D57C29'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

comprehensive

author：hotspot 2025-09-28 01:38:12 - browse：28

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： 5 dead in mass shooting on Caribbean island of St. Vincent: Police

focus

explore

Wikipedia

entertainment

leisure time

Wikipedia

Aninfertilityspecialistspointstoahumaneggcellafterinsemination.IVANCOURONNE/AFPviaGettyImagesAstheCo

WSS

6 solutions to address cancer drug shortages and others

WHO recommends second malaria vaccine

5 dead in mass shooting on Caribbean island of St. Vincent: Police

The biotech scorecard for Q4: 16 stock

RSV injection headlines need to be accurate for good uptake

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

hotspot

comprehensive

focus

As demand for Covid shots wanes, Moderna seeks its next success

Hormonal contraceptives don’t actually treat endometriosis

The high cost of giving birth even with insurance

After a decade, new Gardasil ad campaign gets it (mostly) right

ChatGPT in medicine: STAT answers readers' burning questions

The biotech scorecard for Q4: 16 stock

Malaria cases in Florida and Texas: Here’s what you need to know

Flu, Covid vaccination rates decline, new survey data show

Dobbs anniversary: the lost opportunity of abortion as health care

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

explore

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

The stock market has soared this year, but will it last? Experts weigh in

Dementia risk linked to living in disadvantaged areas: Study

Sanders wants to replace patents with prizes for drug inventions

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Stanford president’s abrupt resignation sparks debate

Wikipedia

entertainment

leisure time

Wikipedia